Skip to content

Oruka Therapeutics, Inc. ORKA Deferred Tax Liabilities

Deferred Tax Liabilities at other companies

MYR Group logo
MYR GroupMYRG
$49.91M-5.0%
Piper Sandler logo
Piper SandlerPIPR
$615K+6.8%
CHE
ChemedCHE
$14.58M+23.8%
MSA
Mine Safety Appliances CompanyMSA
$127M+17.5%
Americold Realty Trust logo
Americold Realty TrustCOLD
$92.88M-21.9%
EPAM Systems logo
EPAM SystemsEPAM
$73.8M-21.7%

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$5.03B+533%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilities.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s deferred tax liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s deferred tax liabilities?
Oruka Therapeutics, Inc. (ORKA) reported deferred tax liabilities of $424K in Q4 2025.
What does deferred tax liabilities mean?
Future tax obligations from temporary differences — most commonly accelerated tax depreciation that creates higher current tax deductions than book depreciation.